Skip to main content

What the FDA labels say about taking them together

Bosentan and macimorelin

Macimorelin's FDA label of February 18, 2026 names bosentan in its drug interactions section; the bosentan label PlainMeds reads does not name macimorelin. The macimorelin label: “Cytochrome P450 (CYP) 3A4 Inducers Co-administration of a strong CYP3A4 inducer with MACRILEN may reduce the plasma macimorelin concentrations and may lead to false positive test results.”

Check it at the source: the bosentan FDA label on DailyMed (effective November 17, 2025, Actelion Pharmaceuticals US, Inc.); the macimorelin FDA label on DailyMed (effective February 18, 2026, Aeterna Zentaris GmbH).

What does the bosentan label say about macimorelin?

Bosentan's label (effective November 17, 2025) does not name macimorelin in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Tracleer), Actelion Pharmaceuticals US, Inc., effective November 17, 2025 (SPL set 749e42fb-2fe0-45dd-9268-b43bb3f4081c), via openFDA; the full label on DailyMed

What does the macimorelin label say about bosentan?

Macimorelin label, drug interactions

Cytochrome P450 (CYP) 3A4 Inducers Co-administration of a strong CYP3A4 inducer with MACRILEN (e.g., carbamazepine, enzalutamide, mitotane, phenytoin, rifampin, St. John's wort, bosentan, efavirenz, etravirine, modafinil, armodafinil, rufinamide) may reduce the plasma macimorelin concentrations and may lead to false positive test results.

Source: FDA drug label (Macrilen), Aeterna Zentaris GmbH, effective February 18, 2026 (SPL set aeb30f1a-4815-47ae-a2cb-b6b4e26372e1), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

5Bosentan generic labelers
0Macimorelin generic labelers
BosentanMacimorelin
Labeled forPulmonary arterial hypertensionn/a
Boxed warningYesNo
Pharmacy cost (NADAC)n/an/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?